US 9833437
Small molecule inhibitor of MYD88 for therapeutic treatment against alphavirus and staphylococcal enterotoxin infections and toxin exposure
granted A61KA61K31/4025A61P
Quick answer
US patent 9833437 (Small molecule inhibitor of MYD88 for therapeutic treatment against alphavirus and staphylococcal enterotoxin infections and toxin exposure) held by The United States of America as represented by the Secretary of the Army expires Mon Nov 30 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as represented by the Secretary of the Army
- Grant date
- Tue Dec 05 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 30 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/4025, A61P, A61P31/04, A61P31/12